nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.165	0.23	CbGbCtD
Nitrofurantoin—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.15	0.208	CbGbCtD
Nitrofurantoin—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.15	0.208	CbGbCtD
Nitrofurantoin—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.143	0.199	CbGbCtD
Nitrofurantoin—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.111	0.154	CbGbCtD
Nitrofurantoin—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.00127	CcSEcCtD
Nitrofurantoin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00127	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00126	CcSEcCtD
Nitrofurantoin—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000351	0.00126	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00126	CcSEcCtD
Nitrofurantoin—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00035	0.00126	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00125	CcSEcCtD
Nitrofurantoin—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00125	CcSEcCtD
Nitrofurantoin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000349	0.00125	CcSEcCtD
Nitrofurantoin—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00125	CcSEcCtD
Nitrofurantoin—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00124	CcSEcCtD
Nitrofurantoin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00124	CcSEcCtD
Nitrofurantoin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000346	0.00124	CcSEcCtD
Nitrofurantoin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00123	CcSEcCtD
Nitrofurantoin—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00123	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.00123	CcSEcCtD
Nitrofurantoin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000343	0.00123	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00123	CcSEcCtD
Nitrofurantoin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00123	CcSEcCtD
Nitrofurantoin—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00123	CcSEcCtD
Nitrofurantoin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000342	0.00123	CcSEcCtD
Nitrofurantoin—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000341	0.00123	CcSEcCtD
Nitrofurantoin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00122	CcSEcCtD
Nitrofurantoin—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00034	0.00122	CcSEcCtD
Nitrofurantoin—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00122	CcSEcCtD
Nitrofurantoin—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000339	0.00121	CcSEcCtD
Nitrofurantoin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00121	CcSEcCtD
Nitrofurantoin—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00121	CcSEcCtD
Nitrofurantoin—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000336	0.00121	CcSEcCtD
Nitrofurantoin—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.0012	CcSEcCtD
Nitrofurantoin—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000335	0.0012	CcSEcCtD
Nitrofurantoin—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000334	0.0012	CcSEcCtD
Nitrofurantoin—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000334	0.0012	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.0012	CcSEcCtD
Nitrofurantoin—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.00119	CcSEcCtD
Nitrofurantoin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.00119	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000331	0.00119	CcSEcCtD
Nitrofurantoin—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00119	CcSEcCtD
Nitrofurantoin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00119	CcSEcCtD
Nitrofurantoin—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000328	0.00118	CcSEcCtD
Nitrofurantoin—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000327	0.00117	CcSEcCtD
Nitrofurantoin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000326	0.00117	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000326	0.00117	CcSEcCtD
Nitrofurantoin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000325	0.00117	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00116	CcSEcCtD
Nitrofurantoin—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00116	CcSEcCtD
Nitrofurantoin—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.00116	CcSEcCtD
Nitrofurantoin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00116	CcSEcCtD
Nitrofurantoin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000322	0.00116	CcSEcCtD
Nitrofurantoin—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00115	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.00115	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00115	CcSEcCtD
Nitrofurantoin—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.00115	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00032	0.00115	CcSEcCtD
Nitrofurantoin—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00115	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00115	CcSEcCtD
Nitrofurantoin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000318	0.00114	CcSEcCtD
Nitrofurantoin—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000316	0.00113	CcSEcCtD
Nitrofurantoin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000315	0.00113	CcSEcCtD
Nitrofurantoin—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000315	0.00113	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000315	0.00113	CcSEcCtD
Nitrofurantoin—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00112	CcSEcCtD
Nitrofurantoin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000313	0.00112	CcSEcCtD
Nitrofurantoin—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000313	0.00112	CcSEcCtD
Nitrofurantoin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000312	0.00112	CcSEcCtD
Nitrofurantoin—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00112	CcSEcCtD
Nitrofurantoin—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00112	CcSEcCtD
Nitrofurantoin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000311	0.00112	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00111	CcSEcCtD
Nitrofurantoin—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.00111	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00111	CcSEcCtD
Nitrofurantoin—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00111	CcSEcCtD
Nitrofurantoin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000309	0.00111	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00111	CcSEcCtD
Nitrofurantoin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000307	0.0011	CcSEcCtD
Nitrofurantoin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000307	0.0011	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.0011	CcSEcCtD
Nitrofurantoin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.0011	CcSEcCtD
Nitrofurantoin—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.0011	CcSEcCtD
Nitrofurantoin—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000305	0.00109	CcSEcCtD
Nitrofurantoin—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00109	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000303	0.00109	CcSEcCtD
Nitrofurantoin—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00108	CcSEcCtD
Nitrofurantoin—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000302	0.00108	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00108	CcSEcCtD
Nitrofurantoin—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00108	CcSEcCtD
Nitrofurantoin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.0003	0.00108	CcSEcCtD
Nitrofurantoin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00107	CcSEcCtD
Nitrofurantoin—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00107	CcSEcCtD
Nitrofurantoin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.00107	CcSEcCtD
Nitrofurantoin—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.00107	CcSEcCtD
Nitrofurantoin—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00107	CcSEcCtD
Nitrofurantoin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000297	0.00106	CcSEcCtD
Nitrofurantoin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000297	0.00106	CcSEcCtD
Nitrofurantoin—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00106	CcSEcCtD
Nitrofurantoin—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00106	CcSEcCtD
Nitrofurantoin—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00106	CcSEcCtD
Nitrofurantoin—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00106	CcSEcCtD
Nitrofurantoin—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00106	CcSEcCtD
Nitrofurantoin—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00106	CcSEcCtD
Nitrofurantoin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00106	CcSEcCtD
Nitrofurantoin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000292	0.00105	CcSEcCtD
Nitrofurantoin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00105	CcSEcCtD
Nitrofurantoin—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.00104	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00104	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00104	CcSEcCtD
Nitrofurantoin—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00103	CcSEcCtD
Nitrofurantoin—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.00103	CcSEcCtD
Nitrofurantoin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.00103	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00103	CcSEcCtD
Nitrofurantoin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000287	0.00103	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00103	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00103	CcSEcCtD
Nitrofurantoin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000286	0.00102	CcSEcCtD
Nitrofurantoin—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.00102	CcSEcCtD
Nitrofurantoin—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.00102	CcSEcCtD
Nitrofurantoin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00102	CcSEcCtD
Nitrofurantoin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000283	0.00102	CcSEcCtD
Nitrofurantoin—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000283	0.00101	CcSEcCtD
Nitrofurantoin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000283	0.00101	CcSEcCtD
Nitrofurantoin—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00101	CcSEcCtD
Nitrofurantoin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000281	0.00101	CcSEcCtD
Nitrofurantoin—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00101	CcSEcCtD
Nitrofurantoin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00101	CcSEcCtD
Nitrofurantoin—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.001	CcSEcCtD
Nitrofurantoin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.001	CcSEcCtD
Nitrofurantoin—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000277	0.000995	CcSEcCtD
Nitrofurantoin—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000277	0.000995	CcSEcCtD
Nitrofurantoin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000277	0.000995	CcSEcCtD
Nitrofurantoin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000277	0.000993	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.000991	CcSEcCtD
Nitrofurantoin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00099	CcSEcCtD
Nitrofurantoin—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000276	0.000989	CcSEcCtD
Nitrofurantoin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000274	0.000984	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.000982	CcSEcCtD
Nitrofurantoin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000274	0.000981	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00098	CcSEcCtD
Nitrofurantoin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000273	0.000978	CcSEcCtD
Nitrofurantoin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000272	0.000975	CcSEcCtD
Nitrofurantoin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000272	0.000975	CcSEcCtD
Nitrofurantoin—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.000974	CcSEcCtD
Nitrofurantoin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000271	0.000973	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.000972	CcSEcCtD
Nitrofurantoin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.000971	CcSEcCtD
Nitrofurantoin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000269	0.000967	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000966	CcSEcCtD
Nitrofurantoin—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.000965	CcSEcCtD
Nitrofurantoin—Headache—Abacavir—acquired immunodeficiency syndrome	0.000268	0.000961	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000958	CcSEcCtD
Nitrofurantoin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.000957	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000946	CcSEcCtD
Nitrofurantoin—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000263	0.000944	CcSEcCtD
Nitrofurantoin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00094	CcSEcCtD
Nitrofurantoin—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00094	CcSEcCtD
Nitrofurantoin—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.000938	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.000937	CcSEcCtD
Nitrofurantoin—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.000935	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00093	CcSEcCtD
Nitrofurantoin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000258	0.000927	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000927	CcSEcCtD
Nitrofurantoin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000926	CcSEcCtD
Nitrofurantoin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.000926	CcSEcCtD
Nitrofurantoin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000258	0.000924	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000922	CcSEcCtD
Nitrofurantoin—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.000921	CcSEcCtD
Nitrofurantoin—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.000914	CcSEcCtD
Nitrofurantoin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000254	0.000911	CcSEcCtD
Nitrofurantoin—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000253	0.000909	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000908	CcSEcCtD
Nitrofurantoin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000252	0.000903	CcSEcCtD
Nitrofurantoin—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.000902	CcSEcCtD
Nitrofurantoin—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.0009	CcSEcCtD
Nitrofurantoin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Nitrofurantoin—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Nitrofurantoin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.000899	CcSEcCtD
Nitrofurantoin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.000895	CcSEcCtD
Nitrofurantoin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.000891	CcSEcCtD
Nitrofurantoin—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00088	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00088	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000876	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.000874	CcSEcCtD
Nitrofurantoin—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000867	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.000867	CcSEcCtD
Nitrofurantoin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000866	CcSEcCtD
Nitrofurantoin—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.000861	CcSEcCtD
Nitrofurantoin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000861	CcSEcCtD
Nitrofurantoin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00086	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00086	CcSEcCtD
Nitrofurantoin—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000859	CcSEcCtD
Nitrofurantoin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.000853	CcSEcCtD
Nitrofurantoin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.000853	CcSEcCtD
Nitrofurantoin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00085	CcSEcCtD
Nitrofurantoin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000236	0.000847	CcSEcCtD
Nitrofurantoin—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000839	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000838	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000834	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000834	CcSEcCtD
Nitrofurantoin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000232	0.000832	CcSEcCtD
Nitrofurantoin—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000831	CcSEcCtD
Nitrofurantoin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000831	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.000828	CcSEcCtD
Nitrofurantoin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000826	CcSEcCtD
Nitrofurantoin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.000816	CcSEcCtD
Nitrofurantoin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000813	CcSEcCtD
Nitrofurantoin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.000804	CcSEcCtD
Nitrofurantoin—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.0008	CcSEcCtD
Nitrofurantoin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.0008	CcSEcCtD
Nitrofurantoin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000223	0.0008	CcSEcCtD
Nitrofurantoin—POR—blood—acquired immunodeficiency syndrome	0.000222	0.115	CbGeAlD
Nitrofurantoin—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000796	CcSEcCtD
Nitrofurantoin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000221	0.000793	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00079	CcSEcCtD
Nitrofurantoin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000788	CcSEcCtD
Nitrofurantoin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.000786	CcSEcCtD
Nitrofurantoin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000778	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000775	CcSEcCtD
Nitrofurantoin—POR—bone marrow—acquired immunodeficiency syndrome	0.000215	0.111	CbGeAlD
Nitrofurantoin—POR—spinal cord—acquired immunodeficiency syndrome	0.000214	0.111	CbGeAlD
Nitrofurantoin—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000763	CcSEcCtD
Nitrofurantoin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000763	CcSEcCtD
Nitrofurantoin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.000756	CcSEcCtD
Nitrofurantoin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000755	CcSEcCtD
Nitrofurantoin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.000752	CcSEcCtD
Nitrofurantoin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000749	CcSEcCtD
Nitrofurantoin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000747	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000746	CcSEcCtD
Nitrofurantoin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000745	CcSEcCtD
Nitrofurantoin—POR—vagina—acquired immunodeficiency syndrome	0.000206	0.106	CbGeAlD
Nitrofurantoin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000726	CcSEcCtD
Nitrofurantoin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000723	CcSEcCtD
Nitrofurantoin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00072	CcSEcCtD
Nitrofurantoin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000717	CcSEcCtD
Nitrofurantoin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000712	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000711	CcSEcCtD
Nitrofurantoin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000706	CcSEcCtD
Nitrofurantoin—POR—lung—acquired immunodeficiency syndrome	0.000195	0.101	CbGeAlD
Nitrofurantoin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000695	CcSEcCtD
Nitrofurantoin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000693	CcSEcCtD
Nitrofurantoin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000693	CcSEcCtD
Nitrofurantoin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000676	CcSEcCtD
Nitrofurantoin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000669	CcSEcCtD
Nitrofurantoin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000669	CcSEcCtD
Nitrofurantoin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000663	CcSEcCtD
Nitrofurantoin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000661	CcSEcCtD
Nitrofurantoin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000659	CcSEcCtD
Nitrofurantoin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000644	CcSEcCtD
Nitrofurantoin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000639	CcSEcCtD
Nitrofurantoin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000638	CcSEcCtD
Nitrofurantoin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000634	CcSEcCtD
Nitrofurantoin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000625	CcSEcCtD
Nitrofurantoin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000614	CcSEcCtD
Nitrofurantoin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000609	CcSEcCtD
Nitrofurantoin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000605	CcSEcCtD
Nitrofurantoin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000601	CcSEcCtD
Nitrofurantoin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000574	CcSEcCtD
Nitrofurantoin—POR—brain—acquired immunodeficiency syndrome	0.000138	0.0712	CbGeAlD
Nitrofurantoin—POR—lymph node—acquired immunodeficiency syndrome	0.000133	0.0688	CbGeAlD
Nitrofurantoin—ABCG2—blood—acquired immunodeficiency syndrome	0.000103	0.0533	CbGeAlD
Nitrofurantoin—ABCG2—bone marrow—acquired immunodeficiency syndrome	9.99e-05	0.0516	CbGeAlD
Nitrofurantoin—ABCG2—spinal cord—acquired immunodeficiency syndrome	9.95e-05	0.0513	CbGeAlD
Nitrofurantoin—ABCG2—vagina—acquired immunodeficiency syndrome	9.57e-05	0.0494	CbGeAlD
Nitrofurantoin—ABCG2—lung—acquired immunodeficiency syndrome	9.05e-05	0.0467	CbGeAlD
Nitrofurantoin—ABCG2—brain—acquired immunodeficiency syndrome	6.41e-05	0.0331	CbGeAlD
Nitrofurantoin—ABCG2—lymph node—acquired immunodeficiency syndrome	6.19e-05	0.032	CbGeAlD
